HER2-Positive Breast Carcinoma — Research

HER2-Positive Breast Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-14	4,992	`("HER2-Positive Breast Carcinoma"[tiab] OR "HER2 Positive Breast Cancer"[tiab] OR "HER2 Overexpressing Breast Carcinoma"[tiab] OR "HER2 Overexpressing Subtype of Breast Carcinoma"[tiab] OR "ERBB2 Overexpressing Subtype of Breast Carcinoma"[tiab])`	2026-09-14	pubmed
Last 5 years	2021-01-01 → 2026-12-31	2,511	`("HER2-Positive Breast Carcinoma"[tiab] OR "HER2 Positive Breast Cancer"[tiab] OR "HER2 Overexpressing Breast Carcinoma"[tiab] OR "HER2 Overexpressing Subtype of Breast Carcinoma"[tiab] OR "ERBB2 Overexpressing Subtype of Breast Carcinoma"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-14	pubmed
Last 12 months	2025-09-14 → 2026-09-14	568	`("HER2-Positive Breast Carcinoma"[tiab] OR "HER2 Positive Breast Cancer"[tiab] OR "HER2 Overexpressing Breast Carcinoma"[tiab] OR "HER2 Overexpressing Subtype of Breast Carcinoma"[tiab] OR "ERBB2 Overexpressing Subtype of Breast Carcinoma"[tiab]) AND (2025/09/14:2026/09/14[dp])`	2026-09-14	pubmed

Data updated 17 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (39)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–39 of 39 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
· J Clin Oncol · 2013 · PMID 23382472 · validated civic_curation pubmed
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.
· Breast Cancer Res Treat · 2011 · PMID 21594665 · validated civic_curation pubmed
Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer.
· Clin Cancer Res · 2016 · PMID 26920887 · validated civic_curation pubmed